title: Clinical importance of estrogen receptor beta isoforms in breast cancer.
authors.forename: Valerie
authors.initials: V
authors.lastname: Speirs
authors.forename: Andrew R
authors.initials: AR
authors.lastname: Green
authors.forename: Thomas A
authors.initials: TA
authors.lastname: Hughes
authors.forename: Ian O
authors.initials: IO
authors.lastname: Ellis
authors.forename: Philippa T K
authors.initials: PT
authors.lastname: Saunders
authors.forename: Abeer M
authors.initials: AM
authors.lastname: Shaaban
mesh_terms: D014408:Biomarkers, Tumor / Q000032:analysis*; D001943:Breast Neoplasms / Q000737:chemistry* / Q000188:drug therapy; D019008:Drug Resistance, Neoplasm; D020847:Estrogen Receptor Modulators / Q000627:therapeutic use*; D047629:Estrogen Receptor beta / Q000032:analysis*; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D011237:Predictive Value of Tests; D020033:Protein Isoforms; D015203:Reproducibility of Results; D016896:Treatment Outcome
chemical_list: D014408:Biomarkers, Tumor; D020847:Estrogen Receptor Modulators; D047629:Estrogen Receptor beta; D020033:Protein Isoforms